Kohei Nakachi

机构：Tochigi Cancer Center, National Cancer Center Hospital East · ORCID：0000-0002-7053-5778

发表论文 95 篇 · 总被引 3357 次 · h-index 23

代表论文

• Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma (2011 · European Journal of Cancer · 被引 578)
• Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival (2012 · Clinical Cancer Research · 被引 304)
• Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial (2023 · The Lancet · 被引 253)
• Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients (2016 · OncoImmunology · 被引 178)
• Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study (2014 · Journal of Gastroenterology · 被引 92)
• A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407) (2022 · European Journal of Cancer · 被引 91)